Decoding D.C. health policy and politics.
About D.C. Direct
What happens in Washington D.C. impacts virtually every healthcare organization in America given the complex legislative, regulatory, and legal framework that determines how health care is reimbursed and delivered. D.C. Direct from Leavitt Partners, an HMA company offers a robust intelligence product that helps our clients anticipate and interpret key federal health policy, political, and personnel developments.
The Dynamic Health Policy Landscape
Congress and the Administration are constantly working to balance the demand for quality and affordable healthcare, access to insurance coverage and care, control of federal spending, and a more equitable and sustainable approach to our complex systems. Organizations seeking to influence the outcome of these policy debates, and thrive in this regulatory environment, must have the most current information informed by partners who understand the complexity of the process as well as the importance of the underlying policy under consideration.
Transforming Information to Insights
Leavitt Partners’ D.C. Direct intelligence is designed by our experts who have worked in and around Washington for decades. This content not only helps clients stay abreast of key federal health policy developments each week, but also explains why they matter.
- We provide insights on the latest headlines and the behind-the-scenes changes that matter most.
- We help clients understand how to navigate key federal health personnel, policy, and political decisions that will ultimately affect every healthcare stakeholder.
- We distill complicated, convoluted sets of information into meaningful, concise, and actionable insights that help clients take appropriate action.
D.C. Policy Forum
The annual D.C. Policy Forum in our Washington, D.C. office features a series of conversations with senior Congressional and Administration staff, moderated by Leavitt Partners’ leadership. Our objective is to provide attendees with a clear understanding of the federal health policy agenda for the coming year.
D.C. Pulse Weekly Virtual Meetings
These weekly 45-minute discussion-driven virtual meetings provide comprehensive, focused intelligence and analysis on legislation, administrative rules and guidance, and personnel, as well as relevant legal and political developments. Conversations involve a rotating cast of leaders in the Leavitt Partners D.C. office who have previous experience in the halls of Congress and Administrations. Recordings of virtual meetings are made available for clients to listen to at their convenience.
Federal Insights Briefs
Once or more per week, we provide analysis of the most important federal health policy developments coming out of Congress and Administration and help you understand what actions are most relevant and provide insights on why these actions matter. On the other end of Pennsylvania Avenue, Congress’ health policy activities may take the form of legislation, oversight actions, or political developments. We provide context and analysis to explain how these policy developments connect the broader trends shaping the evolution of American healthcare.
Issue Briefs & Forecasts
As specific proposals come to light, we produce written policy briefs on major federal health policy issues that are poised to have a significant impact on healthcare stakeholders. We occasionally provide access to other convenings and broadcasts to delve into key topics and political events.
Meet our experts.
Investment
The cost for D.C. Direct federal policy intelligence is $2,000 per month as a standalone service. For more information or to get started, email [email protected].
Why Leavitt Partners
The Leavitt Partners team is comprised of experienced policymakers and staffers whose experience spans the executive and legislative branches of government. As former staff and political appointees, our team members know the regulatory and legislative processes firsthand. Our staff also has deep policy expertise, having helped write significant health care legislation and regulation during their time in public service, including Medicare Part D, the Affordable Care Act, the Medicare Access and CHIP Reauthorization Act (MACRA), the 21st Century Cures Act, various FDA User Fee Acts, the SUPPORT Act, and the Drug Supply Chain Security Act. As an HMA company, we also bring a broader set of health policy and finance experts across a broad set of domains who may contribute insights to D.C. Direct materials.